TheraRadar
Clinical-Stage Companies / Heron

Heron

Pre-Approval PRO BETA
⚫

Inactive Company

No clinical trial activity in 3+ years. This company may have been acquired, shut down, or pivoted away from clinical development. Last trial started: 7/1/2023

22
Total Trials
5
Phase 3
13
Phase 2
0
Recruiting
182
Score

Pipeline by Phase

Phase 3
5
Phase 2
13
Phase 1
1

Therapeutic Focus

Postoperative Pain Analgesia Bunions COVID-19 Chemotherapy-induced Nausea and Vomiting

Clinical Trials (22)

NCT03974932 Phase 3 COMPLETED

Total Knee Arthroplasty (TKA) Study of HTX-011 in an Multimodal Analgesic Regimen (MMA) Regimen

Started: 6/5/2019

NCT03237481 Phase 3 COMPLETED

Phase 3 Herniorrhaphy Study for Postoperative Analgesia (EPOCH 2)

Started: 7/31/2017

NCT03295721 Phase 3 COMPLETED

Bunionectomy Study for Postoperative Analgesia (EPOCH 1)

Started: 10/24/2017

NCT02106494 Phase 3 COMPLETED

A Prospective, Multicenter, Study of APF530 (Granisetron) SC for Prevention of CINV in Patients Receiving HEC

Started: 3/1/2014

NCT03907176 Phase 3 COMPLETED

Study of Post-Herniorrhaphy Non-opioid MMA Regimens

Started: 4/4/2019

NCT03922048 Phase 2 WITHDRAWN

Pediatric Postoperative Analgesia Herniorrhaphy Study

Started: 7/1/2023

NCT04470622 Phase 2 TERMINATED

Aprepitant Injectable Emulsion in Patients With COVID-19 (GUARDS-1)

Started: 7/20/2020

NCT03718039 Phase 2 COMPLETED

Phase 2 Bunionectomy HTX-011 Administration Study

Started: 10/24/2018

NCT02504580 Phase 2 COMPLETED

Pilot Herniorrhaphy Study for Postoperative Analgesia

Started: 7/1/2015

NCT03015532 Phase 2 COMPLETED

Total Knee Arthroplasty Infiltration Study for Postoperative Analgesia

Started: 1/13/2017

NCT03011333 Phase 2 COMPLETED

Phase 2B Upper Extremity Nerve Block Study

Started: 1/14/2017

NCT03695367 Phase 2 COMPLETED

Phase 2 Herniorrhaphy Study for Opioid Elimination

Started: 10/1/2018

NCT02689258 Phase 2 COMPLETED

Evaluation of the Efficacy and Safety of HTX-011 for Postoperative Analgesia Following Abdominoplasty Surgery

Started: 2/23/2016

NCT02762929 Phase 2 COMPLETED

Evaluation of the Efficacy and Safety of Locally Administered HTX-011 for Postoperative Analgesia Following Bunionectomy

Started: 5/1/2016

NCT04911062 Phase 2 COMPLETED

HTX-011 in Spinal Surgery

Started: 4/7/2022

NCT03955211 Phase 2 COMPLETED

HTX-011 Administration Study in Planned Caesarean Section Procedure

Started: 6/24/2019

NCT02471898 Phase 2 COMPLETED

A Phase 2, Two-Part Evaluation of the Efficacy and Safety of Locally Administered HTX-011 for Postoperative Analgesia Following Bunionectomy

Started: 6/1/2015

NCT04398329 Phase 1 COMPLETED

Dose-Escalation Study of HTX-034 Following Bunionectomy

Started: 5/8/2020

NCT06109415 Phase 4 COMPLETED

A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE.

Started: 10/20/2021

NCT06109428 Phase 4 COMPLETED

A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE

Started: 10/12/2021

NCT04102267 Phase 4 COMPLETED

Extended Delivery of Bupivacaine Study in Herniorrhaphy

Started: 7/2/2018

NCT03705065 Phase 4 COMPLETED

Bupivacaine HCl PK and Safety in Augmentation Mammoplasty

Started: 9/19/2018

Drug Candidates

HTX-011 Bupivacaine HCl Aprepitant injectable emulsion +/- Bupivacaine HCl HTX-002 Bupivacaine HCI (Marcaine) HTX-011A HTX-011B HTX-009 Bupivicaine HCl
Activity Status: Inactive
Last Trial Started: 7/1/2023
Last Trial Ended: 8/26/2022
Trials (12 months): 0
Completed Trials: 20
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.